Novartis - Zaditen

🧴 Description

Zaditen by Novartis is a pediatric oral antihistamine and mast cell stabilizer used as an adjunct treatment for mild atopic asthma in children. It contains the active ingredient Ketotifen, which helps reduce the frequency and severity of asthma symptoms by stabilizing mast cells and blocking histamine release.

Zaditen is not intended for acute asthma attacks, but is beneficial for long-term management of allergic asthma in children aged 6 months to 12 years, especially those with atopic predisposition.

✅ Benefits

• ✔️ Reduces the frequency of asthma episodes in children with mild atopic asthma

• ✔️ Acts as a mast cell stabilizer and antihistamine

• ✔️ Can prevent worsening of symptoms over time

• ✔️ Suitable for long-term use under pediatric supervision

• ✔️ Helps manage allergy-induced respiratory inflammation

💡 How to Use

• ➡️ Children 6 months – 3 years: 0.05 mg/kg orally, twice daily

• ➡️ Children over 3 years: 1 mg orally, twice daily

• ➡️ Start with half-dose, increase to full dose over 5 days to reduce side effects
  ⚠️ Not for acute asthma attacks or use in adults
  ⚠️ Always administer under medical supervision

⚠️ Common Side Effects

• Weight gain

• Increased appetite

• Rash or nosebleeds

• Abdominal discomfort

• Puffy eyelids

• Sleep disturbances

• Upper respiratory infections

❗ This is not a complete list. For additional information, consult your pediatrician.

🔬 Key Active Ingredient

• Ketotifen 1 mg / 5 ml – antihistamine and mast cell stabilizer for pediatric use

🧪 Ingredients (INCI Highlights)

Ketotifen fumarate, sorbitol solution, methyl paraben, propyl paraben, purified water, flavoring agents.